Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Arquivos De Neuro-Psiquiatria|November 12, 2013
Nearly one-half of Brazilian patients with multiple sclerosis using natalizumab are DNA-JC virus positiveYara Dadalti Fragoso, Maria Fernanda Mendes, Walter Oleschko Arruda, et al.
Expert Review of Clinical Pharmacology|January 23, 2016
Alternatives for reducing relapse rate when switching from natalizumab to fingolimod in multiple sclerosisYara Dadalti Fragoso, Tarso Adoni, Soniza Vieira Alves-Leon, et al.
Arquivos De Neuro-Psiquiatria|September 26, 2019
Migraine in 746 patients with multiple sclerosisYara Dadalti Fragoso, Tarso Adoni, Soniza V Alves-Leon, et al.
Arquivos De Neuro-Psiquiatria|January 19, 2017
No correlation was observed between vitamin D levels and disability of patients with multiple sclerosis between latitudes 18° and 30° SouthYara Dadalti Fragoso, Tarso Adoni, Soniza Vieira Alves-Leon, et al.
Neurology|October 6, 2021
Associations of Disease-Modifying Therapies With COVID-19 Severity in Multiple SclerosisSteve Simpson-Yap, Edward De Brouwer, Tomas Kalincik, et al.
Arquivos De Neuro-Psiquiatria|November 12, 2013
Multiple sclerosis starting before the age of 18 years: the Brazilian experienceYara Dadalti Fragoso, Maria Lucia Brito Ferreira, Nivea de Macedo Oliveira Morales, et al.
Arquivos De Neuro-Psiquiatria|September 20, 2018
Brazilian Consensus for the Treatment of Multiple Sclerosis: Brazilian Academy of Neurology and Brazilian Committee on Treatment and Research in Multiple SclerosisVanessa Daccach Marques, Giordani Rodrigues Dos Passos, Maria Fernanda Mendes, et al.
Health Care for Women International|September 5, 2014
Postpartum Treatment With Immunoglobulin Does Not Prevent Relapses of Multiple Sclerosis in the MotherYara Dadalti Fragoso, Tarso Adoni, Soniza Vieira Alves-Leon, et al.
Arquivos De Neuro-Psiquiatria|November 24, 2021
Recommendations by the Scientific Department of Neuroimmunology of the Brazilian Academy of Neurology (DCNI/ABN) and the Brazilian Committee for Treatment and Research in Multiple Sclerosis and Neuroimmunological Diseases (BCTRIMS) on vaccination in general and specifically against SARS-CoV-2 for patients with demyelinating diseases of the central nervous systemJefferson Becker, Lis Campos Ferreira, Alfredo Damasceno, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|August 27, 2021
Clinical Features of COVID-19 on Patients With Neuromyelitis Optica Spectrum DisordersSamira Luisa Apostolos-Pereira, Lis Campos Ferreira, Mateus Boaventura, et al.
Pageof 4